Pacific Biosciences of California Inc reports results for the quarter ended in March - Earnings Summary

Pacific Biosciences of California

09/05/2024 23:06

* Pacific Biosciences of California Inc  PACB.OQ  reported a
quarterly adjusted loss of 29 cents​​ per share for the quarter
ended in March, higher than the same quarter last year, when the
company reported EPS of -36 cents.  The mean expectation of
thirteen analysts for the quarter was for a loss of 28 cents per
share. Wall Street expected results to range from -32 cents
to -23 cents per share.
    * Revenue fell 0.2% to $38.81 million from a year ago;
analysts
expected $42.96 million. 
    * Pacific Biosciences of California Inc's reported EPS for
the
quarter was a loss of 29 cents​.
    * The company reported a quarterly loss of $78.18 million.
    * Pacific Biosciences of California Inc shares had fallen
by 55.2%
this quarter and lost 82.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $3.50 

This summary was machine generated from LSEG data May 9 at 10:05
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.28          -0.29          Missed
 Dec. 31 2023      -0.29          -0.31          Missed
 Sep. 30 2023      -0.33          -0.26          Beat
 Jun. 30 2023      -0.32          -0.28          Beat